Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05987592

BE WELL With Migraine: Brain Education and WELLness With Migraine

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
286 (estimated)
Sponsor
Wake Forest University Health Sciences · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this randomized clinical trial is to evaluate two different non-drug, virtual treatment options designed to improve the lives of patients with migraine. Both interventions involve 8 weekly sessions and an online platform with additional content and learning. Participants can stay on all their medications during this study. Information from this study may help determine how to better treat migraine.

Detailed description

This study involves 8 weekly virtual sessions \& an online platform designed to improve the lives of patients with migraine. Participants from across the United States with migraine may be eligible to participate. This study does not require any in-person visits. All assessments and surveys will be completed virtually and/or online. Participants will independently complete an initial online screen. Participants will attend a scheduled phone or videoconferencing call with a study team member to complete the baseline assessment and learn how to use the online platform. Participants will keep an online daily headache log and complete several online surveys throughout the study.

Conditions

Interventions

TypeNameDescription
BEHAVIORALBrain Education and WELLness with Migraine Group ABehavioral intervention that involves 8 weekly group virtual sessions with an instructor that may help improve migraine, plus access to an online platform with additional content and learning
BEHAVIORALBrain Education and WELLness with Migraine Group BBehavioral intervention that involves 8 weekly group virtual sessions with an instructor that may help improve migraine, plus access to an online platform with additional content and learning

Timeline

Start date
2024-07-31
Primary completion
2026-12-30
Completion
2027-06-30
First posted
2023-08-14
Last updated
2025-05-29

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT05987592. Inclusion in this directory is not an endorsement.